Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
Clinical trial NCT01142089 · COMPLETED
Trial details
- NCT number
- NCT01142089
- Sponsor
- Cosmo Technologies Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-27
- Primary completion
- 2012-06-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.